 |
Adult Immunization Update CME/CE Author Information and Disclosures Release Date: June 25, 2008; Valid for credit through June 25, 2009 | Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 0.5 nursing contact hours (0.5 contact hours are in the area of pharmacology) | | To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details. Contents of This CME/CE Activity- Adult Immunization UpdateKenneth E. Schmader, MD; Kevin J. High, MD, MS; Kristin L. Nichol, MD, MPH, MBA; Michael N. Oxman, MD
Available As: Slides/Video | Slides/Transcript
Legal DisclaimerThe material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Recognize the need for immunizations against herpes zoster
- Assess recent updates to the US Recommended Adult Immunization Schedule
- Implement immunization strategies in clinical practice to overcome adult immunization
barriers
Authors and Disclosures Kenneth E. Schmader, MD
Disclosure: Kenneth E. Schmader, MD, has disclosed that he has received grants for clinical research from Merck. Dr. Schmader has also disclosed that he has served as an advisor or consultant to Merck. Kevin J. High, MD,
MS
Disclosure: Kevin J. High, MD, MS, has disclosed that he has received grants for educational activities from ViroPharma. Dr. High has also disclosed that he has served as an advisor or consultant to and on the speaker's bureau for Merck. Kristin L. Nichol, MD, MPH, MBA
Disclosure: Kristin L. Nichol, MD, MPH, MBA, has disclosed that she has served as an advisor or consultant to
Sanofi Pasteur, GlaxoSmithKline, Novartis, CSL Limited, Merck, and MedImmune. Dr. Nichol has also disclosed that she has received grants for clinical research from Sanofi Pasteur and GlaxoSmithKline. Michael N. Oxman, MD
Disclosure: Michael N. Oxman, MD, has disclosed that he has received grants for clinical research from Merck. Michelle Manzo,
MPH
Disclosure: Michelle Manzo, MPH, has disclosed no relevant financial relationships. |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
This Activity is sponsored by Medscape Continuing Education Provider Unit. Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Awarded 0.5 contact hour(s) of continuing nursing education for RNs and APNs; 0.5 contact hours are in the area of pharmacology. Provider Number: 6FDKKC-PRV-05
Contact This Provider
|
|
